![]() Olpha Olpha (formerly known as Olainfarm) is a company engaged in the development and manufacture of pharmaceutical products. | ![]() ANI Pharmaceuticals ANI Pharmaceuticals develops, manufactures and markets top quality prescription pharmaceuticals, made in the U.S.A. | ![]() Merus Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients. | |
Founding Date | Founding Date 1972 | Founding Date 1996 | Founding Date 2003 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Olaine, LV HQ | Locations Baudette, US HQ Oakville, CA Baudette, US | Locations Utrecht, NL HQ Cambridge, US |
Employees | Employees 2,191 | Employees 33813% increase | Employees 260 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.2 b | Valuation ($) 3.6 b |
Financial | |||
Revenue (est.) | Revenue (est.) €122.2m (FY, 2020) | Revenue (est.) $883.4m (FY, 2025) | Revenue (est.) $36.1m (FY, 2024) |
Cost of goods | Cost of goods €44.5m (FY, 2020) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit €80.1m (FY, 2020) | Gross profit N/A | Gross profit $36.1m (FY, 2024) |
Net income | Net income €9.5m (FY, 2020) | Net income N/A | Net income ($215.3m) (FY, 2024) |

ANI Pharmaceuticals develops, manufactures and markets top quality prescription pharmaceuticals, made in the U.S.A.
View company
Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients.
View company